&w=3840&q=100)
Vedanta, 2 others to trade ex-dividend on June 24; do you own any?
Dividend stocks: Shares of Vedanta, Polycab India, and Alkyl Amines Chemicals are set to remain in spotlight today, June 23, following their announcement of dividend rewards for their shareholders. These shares, BSE data suggest, will trade ex-dividend tomorrow, June 24. The ex-dividend date is when a stock starts trading without the right to receive the declared dividend. To be eligible, investors must own the stock before this date. Companies determine the list of eligible shareholders based on their records on the record date.
Vedanta dividend 2025
Metal and mining major Vedanta informed the exchanges that its board of directors has considered and approved the first interim dividend of ₹7 per equity share on face value of ₹1 per equity share for the Financial Year 2025-26, amounting to ₹2,737 crore.
The record date for the purpose of payment of dividend, Vedanta said, shall be Tuesday, June 24, 2025, and the interim dividend shall be duly paid within the stipulated timelines as prescribed under law.
Polycab India dividend 2025
Wires and cables manufacturer Polycab India 's board has recommended a dividend @ 350 per cent i.e. ₹35 per equity share of face value of ₹10 each for the Financial Year 2024-25, subject to approval of members at the ensuing Annual General Meeting.
"The dividend, if approved by the members in the ensuing Annual General Meeting, will be paid on or before 30 days from the date of the Annual General Meeting," said the company in an exchange filing.
Alkyl Amines Chemicals dividend 2025
Specialty chemicals manufacturer Alkyl Amines Chemicals has informed the exchanges that its board has recommended a final dividend of ₹10 per equity share of ₹2 each (i.e., 500 per cent) for the Financial Year (F.Y.) 2024-25. The dividend is, however, subject to approval by the shareholders at the ensuing Annual General Meeting.
Alkyl Amines Chemicals has fixed Tuesday, June 24, 2025, as the 'record date' for determining entitlement of members to dividend for the financial year ended March 31, 2025, if approved at the AGM.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
8 minutes ago
- New Indian Express
Both AI and GCCs are new ways of growth and not a threat: Nandan Nilekani
Infosys chairman Nandan Nilekani said both Artificial Intelligence (AI) and Global Capability Centres (GCCs) are not a threat to IT services firms and that they are new ways of growth. Answering a shareholder's query on which is a greater threat to an IT service firm- AI or exponential growth of GCCs, Nilekani at the company's 44th Annual General Meeting (AGM) on Wednesday said the current wave of GCC is not about cost arbitrage, it's about innovation arbitrage. "Quite a few companies are setting up research centres, AI/Machine Learning centres, GCCs, and we're helping many of them in this regard. This means that GCCs are no longer our competitors, they're critical clients for us," he said. On AI, he said it is there in every part of the company's client conversations, and that they are seeing strong business traction, mainly driven by Infosys Topaz. Nilekani also answered shareholders on how the company is mitigating business risks considering the present macroeconomic uncertainties. He said, "Infosys is the leader in AI, cloud, data and digital for our clients. Despite macro challenges, we are confident of our positioning both on cost takeout and discretionary spend." He added that the company is continuously investing in reskilling and upskilling its employees in AI. "As of today, we have over 275,000 employees who are trained in AI at different levels of proficiency," he said. Infosys CEO and MD Salil Parekh said India is a strategic market for the company and that it is growing well. "India is a critical geography for us, we work with different Indian entities, for example, with the government on income tax, GST. We are doing work with LIC on next-gen digital capabilities, working with the majority of the banks in India. So, for us, it's a strategic market," he said. He also added that clients are prioritizing strategic AI partnerships using good traction for AI/Gen AI work, which is in software engineering, process optimisation, customer support, advisory services and sales & marketing. Senior executives also mentioned how the company is actively moving to tier-2, 3 cities to enable and attract more talent.
Mint
an hour ago
- Mint
Indogulf Cropsciences IPO: Delhi-based agrotech firm raises ₹58.19 crore from anchor investors ahead of public issue
Indogulf Cropsciences IPO: Indogulf Cropsciences completed its anchor round on Wednesday, 25 June 2025. As per the exchange filing, the agrotech firm raised ₹ 58.19 crore from anchor investors ahead of the public issue. According to the BSE filing, Indogulf Cropsciences allotted a total of 52,43,242 or over 52.43 lakh equity shares to the anchor investors at an allocation price of ₹ 111 per share with a face value of ₹ 10 apiece. Abakkus Diversified Alpha Fund, Viney Growth Fund, Swyom India Alpha Fund, Sunrise Investment Trust, and Rajasthan Global Securities Pvt. Ltd, were the anchor investors who participated in the public issue. Abakkus Diversified Alpha Fund at 48.45 per cent and Viney Growth Fund at 25.77 per cent were the top anchor allotments of the Indogulf Cropsciences IPO, according to the BSE IPO data. 'The company has positioned itself as one of the first few indigenous manufacturers of Pyrazosulfuron Ethyl technical, with 97% purity in India. Its strong market position is further supported by the high entry barriers in the agrochemical sector, including costs and complex approvals,' said the analysts at Anand Rathi, assigning a 'Subscribe' rating to the public issue. As of Wednesday, 25 June 2025, the grey market premium (GMP) of the Indogulf Cropsciences IPO stood at ₹ 11 per share. With the upper price band of ₹ 111 per share, the stocks are expected to be listed in the Indian stock market at ₹ 122 apiece, a listing premium of 9.91 per cent, according to Investorgain data. Grey market premium (GMP) is an indicator of the investors' willingness to apply for a public issue. The GMP remained flat after the anchor round at its current levels. Indogulf Cropsciences is a book-built issue offering a fresh issue of ₹ 160 crore, and an offer-for-sale (OFS) component of 36,03,603 equity shares by the promoter selling stakeholder. The company fixed the price band for the IPO in the range of ₹ 105 to ₹ 111 per share, with a lot size of 135 equity shares per lot. The IPO will open for public subscription on Thursday, 26 June 2025, and is scheduled to close on Monday, 30 June 2025. The firm aims to use the net proceeds from the public issue to address working capital requirements, settle or pay off existing debts, finance capital expenditures for the company, or set up an in-house dry flowable (DF) facility in Haryana, along with general corporate activities. Systematix Corporate Services Limited is the book-running lead manager for the public issue, while Bigshare Services Pvt Ltd is the registrar for the offer. Read all stories by Anubhav Mukherjee
Time of India
an hour ago
- Time of India
‘Largest share sale through QIP': SBI plans Rs 25,000 crore Qualified Institutional Placement; appoints six banks for first share sale in 8 years
State Bank of India (SBI), the nation's most valuable public sector enterprise, is nearing the final stages of selecting several merchant banks to secure up to Rs 25,000 crore through a qualified institutional placement (QIP). Tired of too many ads? go ad free now This marks its first equity offering since 2017, as the bank, which holds 20% of India's total bank credit, seeks to strengthen its common equity tier 1 (CET-1) capital. As of March 2025, SBI's CET-1 stood at 11%. According to industry analysts, this figure ranked amongst the lowest for public sector banks. The board of the bank gave its approval for the QIP on May 3. Should the bank succeed in raising Rs 25,000 crore, it would establish a record for the largest QIP-based share sale in India. QIP serves as a more expedient option compared to rights issues or follow-on public offerings, as it facilitates bulk fund collection from major institutional investors. According to an ET report, the selected banks to oversee the capital raising include Kotak Mahindra Capital Co, ICICI Securities Ltd, HSBC Securities and Capital Markets (India) Pvt Ltd, Citigroup Global Markets India Pvt Ltd, Morgan Stanley India Co Pvt Ltd and SBI Capital Markets Ltd. "The banks have agreed to charge just Rs 1 for this transaction, as it is a matter of league table win rather than fees. It is a prestige battle for banks to be on the mandate to raise money for the largest bank in India, which is a rare occasion," a source told the financial daily. A similar nominal fee structure was last observed during SBI's previous QIP in June 2017, when the bank raised Rs 15,000 crore by issuing 522 million shares. Tired of too many ads? go ad free now "This is a prestigious mandate, so bidding was aggressive. One of the merchant bank's quoted a Rs 1 fee and everyone else had to come to that level," said this person cited above. "The bank wants to augment its CET 1 ratio which is the lowest among public sector banks. Growth wise the bank is well placed with the RoE of 19% is much ahead of the 12% loan growth. But capital can now be raised to cushion the CET which is the plan," another source said, according to the report. State Bank of India plans to approach the market in the coming months. Similar to the previous Qualified Institutional Placement where Life Insurance Corporation subscribed to half the offering, the insurer is expected to acquire a significant portion of shares this time as well. As of March 31, LIC maintains a 9.38 percent ownership in the bank, positioning it as the second-largest shareholder after the central government's 57.43 percent stake. The bank will determine the final timing and quantum based on prevailing market conditions. SBI shares concluded at Rs 800 per share on the BSE, showing a 1% increase from Tuesday's closing price. During this financial year, SBI will receive funds from divesting its 13.19% holding in Yes Bank to Japanese financial institution Sumitomo Mitsui Banking Corporation (SMBC). Additionally, it owns 5.19% in National Stock Exchange, which is expected to generate substantial returns upon the exchange's eventual listing.
